Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2503703, 7 pages
http://dx.doi.org/10.1155/2016/2503703
Research Article

Effects of Berberine on NLRP3 and IL-1β Expressions in Monocytic THP-1 Cells with Monosodium Urate Crystals-Induced Inflammation

1Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China
2Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, Henan 450052, China
3Hubei University of Chinese Medicine, 1 Huangjiahu West Road, Wuhan, Hubei 430065, China

Received 20 June 2016; Accepted 31 July 2016

Academic Editor: Sadiq Umar

Copyright © 2016 Ya-Fei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C.-F. Kuo, M. J. Grainge, W. Zhang, and M. Doherty, “Global epidemiology of gout: prevalence, incidence and risk factors,” Nature Reviews Rheumatology, vol. 11, no. 11, pp. 649–662, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Zhu, B. J. Pandya, and H. K. Choi, “Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008,” Arthritis & Rheumatism, vol. 63, no. 10, pp. 3136–3141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. C. Landis and D. O. Haskard, “Pathogenesis of crystal-induced inflammation,” Current Rheumatology Reports, vol. 3, no. 1, pp. 36–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. P. T. Chapman, H. Yarwood, A. A. Harrison et al., “Endothelial activation in monosodium urate monohydrate crystal-induced inflammation. In vitro and in vivo studies on the roles of tumor necrosis factor α and interleukin-1,” Arthritis & Rheumatism, vol. 40, no. 5, pp. 955–965, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, “Gout-associated uric acid crystals activate the NALP3 inflammasome,” Nature, vol. 440, no. 7081, pp. 237–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Terkeltaub, J. S. Sundy, H. R. Schumacher et al., “The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study,” Annals of the Rheumatic Diseases, vol. 68, no. 10, pp. 1613–1617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Selmi, E. Generali, M. Massarotti, G. Bianchi, and C. A. Sciré, “New treatments for inflammatory rheumatic disease,” Immunologic Research, vol. 60, no. 2-3, pp. 277–288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Shi, L. Xu, Y. Yang, H. Song, H. Pan, and L. Yin, “Suppressive effect of modified Simiaowan on experimental gouty arthritis: an in vivo and in vitro study,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 1038–1044, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-F. Liu, S.-H. Tu, Z. Chen, Y. Wang, Y.-H. Hu, and H. Dong, “Effects of modified Simiao decoction on IL-1β and TNFα secretion in monocytic THP-1 cells with monosodium urate crystals-induced inflammation,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 406816, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Shi, L. Xu, and L. Yin, “Exploring the anti-gout effective utility parts of modified simiao pill,” Journal of Nanjing TCM University, vol. 24, no. 6, pp. 386–387, 2008. View at Google Scholar
  11. L. Yin, X.-D. Shi, and Z.-X. Qian, “Ideas and methods of screening jiaweisimiaowan for treatment of gout and principles of diagnosis,” World Science and Technology—Modernization of Traditional Chinese Medicine and Materia Medica, vol. 8, no. 6, pp. 27–30, 2006. View at Google Scholar
  12. S.-X. Liu, Y.-F. Liu, J.-H. Yin, Y. Zhang, L.-X. Xu, and J. Yang, “Effects of berberine on inflammatory cytokines induced by lipopolysaccharide in THP-1 cells,” International Journal of Endocrinology and Metabolism, vol. 34, no. 4, pp. 233–236, 2014. View at Google Scholar
  13. H. W. Jeong, K. C. Hsu, J.-W. Lee et al., “Berberine suppresses proinflammatory responses through AMPK activation in macrophages,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 4, pp. E955–E964, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-F. Liu and S.-H. Tu, “The review of traditional Chinese medicine in the treatment of gout,” Rsearch of Integrated Traditional Chinese and Western Medicine, vol. 4, no. 1, pp. 44–47, 2012. View at Google Scholar
  15. L. Zhou, L. Liu, X. Liu et al., “Systematic review and meta-analysis of the clinical efficacy and adverse effects of Chinese herbal decoction for the treatment of gout,” PLoS ONE, vol. 9, no. 1, Article ID e85008, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Hua, P. Huang, C.-M. Zhu, X. Yuan, and C.-H. Yu, “Anti-hyperuricemic and nephroprotective effects of Modified Simiao Decoction in hyperuricemic mice,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 248–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Q.-H. Hu, R.-Q. Jiao, X. Wang, Y.-Z. Lv, and L.-D. Kong, “Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice,” Journal of Ethnopharmacology, vol. 128, no. 3, pp. 685–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Li, C. Liu, L. Guo et al., “Ultrafiltration liquid chromatography combined with high-speed countercurrent chromatography for screening and isolating potential α-glucosidase and xanthine oxidase inhibitors from Cortex Phellodendri,” Journal of Separation Science, vol. 37, no. 18, pp. 2504–2512, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. J. Coderre and P. D. Wall, “Ankle joint urate arthritis in rats provides a useful tool for the evaluation of analgesic and anti-arthritic agents,” Pharmacology, Biochemistry and Behavior, vol. 29, no. 3, pp. 461–466, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. T. J. Coderre and P. D. Wall, “Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund's adjuvant,” Pain, vol. 28, no. 3, pp. 379–393, 1987. View at Publisher · View at Google Scholar · View at Scopus
  21. D. M. Rose and R. Liu-Bryan, “Innate immunity in triggering and resolution of acute gouty inflammation,” Current Rheumatology Reports, vol. 8, no. 3, pp. 209–214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Kingsbury, P.-G. Conaghan, and M.-F. McDermott, “The role of the NLRP3 inflammasome in gout,” Journal of Inflammation Research, vol. 4, no. 1, pp. 39–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-T. Dang, W.-G. Xie, M.-C. Zhao et al., “Correlation analysis of expression of NLRP3 gene transcript variant mRNA and clinical examination indexes in patients with gouty arthritis,” Journal of Third Military Medical University, vol. 36, no. 16, pp. 1713–1719, 2014. View at Google Scholar
  24. Q.-B. Yang, J.-G. Zhou, Y.-F. Qing, W.-G. Xie, M.-C. Zhao, and M. Li, “Expression of NLRP3 inflammttsome mRNA in peripheral blood monocytes of patients with gouty arthritis,” Chinese Journal of Rheumatology, vol. 14, no. 10, pp. 686–689, 2010. View at Google Scholar